Professor Maowia M. Mukhtar; Participated in Tackling Infection to Benefit Africa (TIBA) annual meeting held in Durban, South Africa during the period 29 -31 May 2018. The meeting reviewed the progress in TIBA projects and discuss ways to strengthen the collaboration between partner and future training (www.tiba-partnership.org) .
Mrs. Azza Elshafie Bashir Babiker participate din TIBA annual meeting in Durban, South Africa and presented her Ph.D. project as a poster and her presentation was well received.
Professor Maowia Mukhtar: Participated in the launching meeting for EXIT _TB consortium held in Arusha, Tanzania during the period 2-5 July 2018. Participants from Tanzania, Ethiopia, Keya and Uganda and Sudan actively participated in the successful meeting to initiate the activities of the project
EACCR/ NID molecular diagnosis course Salah AbdallaBushara (Ph.D.) student participated in the EACCR/ NID molecular diagnosis course held in Moshi during the period 2 -6 July 2018. The course proved excellent training on molecular diagnosis of neglected, emerging and re emerging disease and was coordinated by dr. Jaffu Chilongolafrom KCRI and Dr. Ester Ngadays from NIMR Tanzania
TIBA-Sudan Advance malaria course TIBA: Tackling Infections to Benefit Africa (TIBA) is an Africa-led, wide-ranging, multi-disciplinary research programme that explores and draws lessons from the ways that different African health systems tackle infectious diseases. TIBA will help empower African scientists to effectively and sustainably tackle neglected tropical diseases (such as schistosomiasis, malaria, trypanosomiasis and lymphatic filariasis), and improve preparedness for epidemics (such as Ebola). Tiba means “to cure an infection” in Swahili.Read More
Leishmaniasis is a disease caused by the protozoan parasites of the genus Leishmania. The infection is transmitted between vertebrate hosts by the bite of blood sucking female phlebotomine sand flies (Diptera, Psychodida). It manifests mainly in three clinical forms: visceral, cutaneous, and mucocutaneous.Book A Consultation